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Background: Maternal smoking is one of the most important modifiable risk factors for low birthweight, which is
strongly associated with increased cardiometabolic disease risk in adulthood. Maternal smoking reduces the levels
of the methyl donor vitamin B12 and is associated with altered DNA methylation at birth. Altered DNA methylation
may be an important mechanism underlying increased disease susceptibility; however, the extent to which this can
be induced in the developing fetus is unknown.
Methods: In this retrospective study, we measured concentrations of cobalt, vitamin B12, and mRNA transcripts
encoding key enzymes in the 1-carbon cycle in 55 fetal human livers obtained from 11 to 21 weeks of gestation
elective terminations and matched for gestation and maternal smoking. DNA methylation was measured at critical
regions known to be susceptible to the in utero environment. Homocysteine concentrations were analyzed in
plasma from 60 fetuses.
Results: In addition to identifying baseline sex differences, we found that maternal smoking was associated with
sex-specific alterations of fetal liver vitamin B12, plasma homocysteine and expression of enzymes in the 1-carbon
cycle in fetal liver. In the majority of the measured parameters which showed a sex difference, maternal smoking
reduced the magnitude of that difference. Maternal smoking also altered DNA methylation at the imprinted gene
IGF2 and the glucocorticoid receptor (GR/NR3C1).
Conclusions: Our unique data strengthen studies linking in utero exposures to altered DNA methylation by
showing, for the first time, that such changes are present in fetal life and in a key metabolic target tissue, human
fetal liver. Furthermore, these data propose a novel mechanism by which such changes are induced, namely
through alterations in methyl donor availability and changes in 1-carbon metabolism.
Keywords: DNA methylation, Liver, Maternal smoking, Vitamin B12* Correspondence: mandy.drake@ed.ac.uk; p.a.fowler@abdn.ac.uk
ˆDeceased
1Endocrinology Unit, University/BHF Centre for Cardiovascular Science,
University of Edinburgh, Queen’s Medical Research Institute, 47 Little France
Crescent, Edinburgh EH16 4TJ, UK
8Division of Applied Medicine, Institute of Medical Sciences, University of
Aberdeen, Foresterhill, Aberdeen AB25 2ZD, UK
Full list of author information is available at the end of the article
© 2015 Drake et al.; licensee BioMed Central. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain
Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article,
unless otherwise stated.
Drake et al. BMC Medicine  (2015) 13:18 Page 2 of 12Background
Exposure to an adverse environment in utero leading to
a reduction in birthweight is associated with a marked
increase in later susceptibility to cardiometabolic and
neuroendocrine disorders [1]. Smoking in pregnancy re-
duces birthweight, body length, and head circumference
at term [2] and is associated with increased cardiovascu-
lar disease risk in the offspring [3,4]. Thus, in addition
to being one of the most important modifiable risk fac-
tors for low birthweight, maternal smoking is potentially
a critical risk factor for a substantial burden of non-
communicable disease in adulthood. Despite public health
advice, the prevalence of smoking during pregnancy re-
mains high: in developed countries up to 25% of pregnant
women smoke and fewer than 4% stop smoking while
pregnant [5].
There is growing interest in the concept that alter-
ations in the epigenome, particularly changes in DNA
methylation, may be an important mechanism linking
the early life environment with later disease risk. Smok-
ing affects DNA methylation in adults [6] and recent
studies in children and adults exposed to cigarette
smoke in utero have reported alterations in global and
site-specific DNA methylation [7-10]. One potential
pathway by which exposure to adverse environmental
conditions, including cigarette smoke in utero, might
impact on DNA methylation is through altered avail-
ability of methyl donors provided by the 1-carbon path-
way [11]. In animal models, the availability of methyl
donors and 1-carbon substrates and co-factors, such as
vitamin B12, during pregnancy is associated with differ-
ences in DNA methylation in the offspring [12,13], and
this may also be relevant to humans [14,15]. Maternal
vitamin B12, a key co-factor in the 1-carbon cycle, is
the major determinant of neonatal vitamin B12 concen-
trations [16] and maternal smoking reduces the con-
centrations of vitamin B12 in pregnant women [17]
and their infants [18].
Based on initial observations of depleted concentra-
tions of cobalt (the central metal ion in vitamin B12) in
second-trimester human fetal livers, reported for the
first time in this article, we hypothesized that exposure
to maternal cigarette smoking would also reduce fetal
vitamin B12 levels. This, in turn, may be associated with
changes in 1-carbon metabolism and with DNA methy-
lation in the fetal liver – a key metabolic target tissue.
Furthermore, since exposure to maternal smoking dur-
ing pregnancy has sex-specific effects on fetal growth
[19,20], the expression of steroidogenic and metabolic
genes in fetal liver [21,22] and on the later risk of being
overweight/obese [23], we postulated that any effects
would be sex-specific. We sought to test these hypoth-
eses directly through study of the effects of prenatal
smoke exposure on the fetal liver.Methods
Sample collection
The collection of fetal material was approved by the
NHS Grampian Research Ethics Committees (REC 04/
S0802/21). Women seeking elective, medical, termina-
tions of pregnancy were recruited with full written, in-
formed, consent by nurses working independently at
Aberdeen Pregnancy Counselling Service. There was no
change in patient treatment or care associated with re-
cruitment to the study and women were able to with-
draw from the study at any point. Fetal normality was
determined at ultrasound scan 2 to 9 days prior to the
termination of pregnancy. Women bearing abnormal fe-
tuses were not included in the study. Only fetuses from
normally-progressing pregnancies, from women over
16 years of age with a good understanding of English, and
between 11 to 21 weeks of gestation, were collected. Fe-
tuses were transported to the laboratory within 30 minutes
of delivery, weighed, crown-rump length recorded, and
sexed. Blood samples were collected by cardiac puncture
ex vivo and plasma was initially stored at −20°C and then
transferred to −85°C after assay. Livers were snap-frozen
in liquid nitrogen and stored at −85°C.
Study design
For local ethical and logistic reasons it is not possible
to prospectively collect specific fetuses for each study;
therefore, studies were performed retrospectively by rigor-
ous selection of already collected fetal tissues, samples,
and data. To ensure accurate classification of fetuses, ex-
posure to cigarette smoke was determined by measuring
fetal plasma cotinine [24]. From a population of 228 fe-
tuses available, two subpopulations were formed based
on the availability of: (A) liver tissue (55 fetuses [21,22])
and (B) plasma measurements (60 fetuses). Of the 60
fetuses in (B), 18 fetuses overlapped with the 55 livers
in (A). Within each subpopulation, the studied fetuses
were matched for gestational age, fetal sex, and mater-
nal smoking/fetal plasma cotinine (Table 1). The aim of
this matching was to ensure that each of the four main
analytical groupings (male, non-smoke-exposed; male,
smoke-exposed; female, non-smoke-exposed; female,
smoke-exposed) contained similar numbers of fetuses
representing similar gestational ages, enabling two-way
ANOVA to be used (see Statistical analysis section below).
We were unable to collect data on maternal diet under
the study ethics but the women were matched for age and
body mass index across the four main analytical groupings
(Table 1).
Hepatic metal content analysis and cobalt speciation
Livers were homogenized using a TissueLyser (Qiagen Ltd.,
Crawley, UK) and were freeze-dried and stored at −80°C
[21]. For total element determination, 100 mg of liver was
Table 1 Morphological data for the mothers and fetuses (mean ± SEM) at census date and then for those allocated to
the liver and plasma cysteine and homocysteine analyses populations
Population Characteristic Male fetuses Female fetuses
Control Smoke-exposed Control Smoke-exposed
Whole population at census date N 57 66 49 56
Maternal indices Age (years) 24 ± 1 25 ± 1 24 ± 1 24 ± 1
Body mass index (BMI) (kg/m2) 25 ± 1 25 ± 1 24 ± 1 25 ± 1
Cigarettes/day 0 11 ± 1 0 12 ± 1
Fetal indices Age (weeks) 14.5 ± 0.3 15.1 ± 0.3 14.9 ± 0.3 14.9 ± 0.3
Weight (g) 73 ± 10a 95 ± 9b 87 ± 11 92 ± 12
Crown-rump length (CRL, mm) 94 ± 4a 106 ± 4b 101 ± 4 102 ± 4
Ponderal index (weight g/[CRL cm3]) 0.067 ± 0.002 0.067 ± 0.002 0.069 ± 0.003 0.067 ± 0.002
Plasma cotinine (ng/mL) 3 ± 1a 40 ± 2b 4 ± 1a 43 ± 2b
Sub-population: methylation and metal N 14 16 14 11
Maternal indices Age (years) 21 ± 1 26 ± 2 25 ± 1 26 ± 2
BMI (kg/m2) 25 ± 2 26 ± 1 24 ± 1 25 ± 2
Cigarettes/day 0 16 ± 2 0 16 ± 2
Fetal indices Age (weeks) 14.0 ± 0.6 14.3 ± 0.4 15.3 ± 0.7 15.8 ± 0.9
Weight (g) 62 ± 18 74 ± 14 100 ± 20 151 ± 34
CRL (mm) 93 ± 8 97 ± 6 103 ± 8 121 ± 9
Ponderal index (weight g/[CRL cm3]) 0.063 ± 0.004 0.070 ± 0.003 0.080 ± 0.007 0.071 ± 0.003
Plasma cotinine (ng/mL) 3 ± 1a 44 ± 3b 3 ± 1a 48 ± 3b
Sub-population: plasma cysteine and
homocysteine
N 14 17 13 16
Maternal indices Age (years) 25 ± 2 24 ± 1 24 ± 2 24 ± 1
BMI (kg/m2) 26 ± 2 25 ± 2 24 ± 1 24 ± 1
Cigarettes/day 0 13 ± 1 0 11 ± 1
Fetal indices Age (weeks) 15.2 ± 0.7 14.9 ± 0.6 15.6 ± 0.7 15.4 ± 0.6
Weight (g) 102 ± 24 89 ± 18 105 ± 21 101 ± 19
CRL (mm) 108 ± 8 105 ± 7 109 ± 8 121 ± 9
Ponderal index (weight g/[CRL cm3]) 0.074 ± 0.005 0.064 ± 0.002 0.065 ± 0.003 0.065 ± 0.003
Plasma cotinine (ng/mL) 5 ± 1a 44 ± 3b 4 ± 3a 41 ± 3b
a,bValues in the same row that do not share a superscript letter are significantly different (P <0.05) due to maternal cigarette smoking. Absence of superscript
letters indicates no significant differences.
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overnight. Hydrogen peroxide (2 mL) was added and the
samples were digested using a MARS5 microwave oven.
The digest was diluted to 10 mL with water (18 MΩ cm,
MilliQ). Elemental standards for calibration were prepared
by appropriate dilutions of multi-element standard Merck
XXI (Merck, UK) and single element solutions of Mo (CPI,
single element solutions) with 5% nitric acid. The samples
and standards were measured using an Agilent 7500c in-
ductively coupled plasma mass spectrometry (ICP-MS)
with on-line addition of Rh-solution (20 μg/L) as an in-
ternal standard. The ICP-MS was used with H2 as reac-
tion gas to remove molecular interferences of ArCl on
As (m/z 75) and ArAr on Se (m/z 78). Certified stand-
ard reference materials (RM8415, TORT-2, DORM-3,BCR-185R, NIST 1,577b) were used to check reprodu-
cibility and accuracy, with both shown to be better than
5%. The hepatic essential element content was expressed
as ng/g dry matter (dm). Cobalamin in its vitamin B12
form was extracted from homogenized liver (30 to
100 mg) using 2.5 mg papain and 10 μL 1% NaCN dis-
solved in 600 μL acetate buffer (pH 4.0). The mixture
was heated to 57°C for 3 h and subsequently boiled in a
water-bath for 10 min and centrifuged. Different cobalt
species were separated using an Agilent Eclipse XDB-C8
(150 × 4.6 mm) column with an eluent containing 0.1%
(v/v) formic acid in a gradient of 10% to 70% MeOH in
20 min. The column was held at 30°C in a column
oven, the injection volume was 100 μL, and the flow
rate was 1 mL/min. Cobalt detection was performed
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internal standard (Rh in 1% nitric acid) was added post-
column via a T-piece before the nebulizer. The column
effluent was split after the column with three quarters
going into the UV/electrospray ionization (ESI)-MS and
one quarter into the ICP-MS using a short length of peek
tubing. ESI-MS (Orbitrap Discovery, Thermo) was used
for some samples in positive ES-FT-mode (resolution
30,000) from 100 to 2,000 m/z using MS/MS in FT-mode
(resolution 7,500) to aid identification of the eluting vita-
min B12. Quantification was performed after calibration
with a cobalt standard solution and corrected for the dif-
ferent elution conditions for the gradient [25]. The limits
of detection for every cobalamin species was 0.9 μg
Co/kg dm or 1.5 nmol/kg (calculated from 3 × SD)
while reproducibility was better than ±15%.Plasma cysteine and homocysteine determination
Fetal plasma homocysteine and cysteine were analyzed
using an Agilent 1100 HPLC system (Agilent Tech-
nologies, Stockport, UK) according to previously pub-
lished in-house protocols [26] based on the original
method of Pfeiffer et al. [27]. Peak integration was per-
formed using Agilent ChemStation software (Agilent
Technologies).Real-time quantitative PCR
Total RNA was extracted from frozen fetal liver samples
(10 to 20 mg) using TRIzol (Life Technologies, Paisley,
UK). Reverse transcription, primer design, and real-time
PCR were as previously described [28-30] and the pri-
mers used are shown in Additional file 1: Table S1. Data
were normalized against a validated combination of
housekeeping genes (B2M, PMM1, TBP) as described
previously [21].Figure 1 Schematic diagrams showing of regions in which methylatio
promoter. (A) The IGF2 gene comprises multiple transcripts originating fro
(shaded in grey). The H19 ICR is situated distal to IGF2. Regions of different
multiple alternate untranslated first exons as indicated (B-H) [33]. PercentagAnalysis of DNA methylation
DNA was extracted from fetal liver using a Qiagen
AllPrep DNA/RNA/Protein mini kit (Qiagen) follo-
wing tissue homogenization using a Qiagen TissueLyser
(Qiagen) and following the manufacturer’s instructions
[31]. Briefly, 1 μg of DNA was subjected to bisulfite con-
version using the Epitect Bisulfite Kit (Qiagen). Pyrose-
quencing was performed to analyze DNA methylation
across a number of regions (Figure 1) as previously de-
scribed for regions known to be important in controlling
the expression of insulin-like growth factor 2 (IGF2): the
IGF2 differentially methylated regions (DMRs) and the
H19 imprinting control region (ICR) [32] and for exons
1(C) and 1(F) of the NR3C1 glucocorticoid receptor
(GR) promoter [31]. All primers were purchased from
Eurogentec (Southampton, UK). Pyrosequencing was
carried out using SQA reagents (Qiagen) on the PSQ™
HS-96A. Data were analyzed using Pyro Q-CpG Soft-
ware (Qiagen). Background non-conversion levels were
determined by inclusion of non-cytosine-guanine dinu-
cleotide (CpG) cytosine controls in all assays and were
between 1 and 3%.
Statistical analysis
Statistical analyses of data were performed using JMP
9.0.2 software (Thomas Learning, London, UK) [21,22].
Normality of data distribution was tested with the Shapiro-
Wilk test and non-normally distributed data were log-
transformed and re-checked for normality prior to
analysis by ANOVA and Tukey-Kramer honestly sig-
nificant difference and T-tests. Where data were not
normalized, or the variances remained unequal, non-
parametric tests were performed (Wilcoxon Test). Care
was taken to ensure that no comparison involved groups
with any difference between smokers and non-smokers
in terms of stage of gestation, avoiding bias. Becausen was assessed including IGF2 and exons 1(F) and 1(C) of the GR
m promoters (P0-P4) which splice into common protein-coding exons
ial methylation are shown underlined. (B) The GR gene also comprises
e methylation was assessed at CpGs within exons 1F, 1-C1 and 1-C3.
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mental changes in expression across the second trimes-
ter, two-way ANOVA was used to test the combined
effects of gestational age (weeks) and maternal smoking
(yes/no and confirmed by fetal plasma cotinine assay)
on morphological and biochemical data and on tran-
script levels.Results
1-carbon metabolism
Effects of fetal sex
Vitamin B12 is an essential component of the 1-carbon
cycle; it is required for the transfer of the C1 unit from
methyltetrahydrofolate to methionine by methionine
synthase (MTR; EC 2.1.1.13), and is a rate-limiting co-
factor for methionine synthase reductase (MTRR; EC
1.16.1.8). Levels of vitamin B12 and cobalt (the central
metal ion in vitamin B12) were significantly lower in
liver from non-exposed male fetuses than in non-
exposed female fetuses (Figure 2A, B). Vitamin B12 acts
as a co-factor for the conversion of homocysteine to
methionine and homocysteine is converted to cysteine
through the actions of cystathionine-β-synthase (EC
4.2.1.22) and cystathionine gamma-lyase (CTH; EC 4.4.1.1).
We therefore also measured fetal plasma homocysteine
and cysteine. Plasma homocysteine and cysteine levels
were higher in non-exposed males compared to females
(Figure 2D, E).Figure 2 Concentrations of cobalt (Co) and vitamin B12 (B12) in the h
smoking on Co and B12, respectively. The ratio between B12 and Co (C) w
females. Circulating fetal cysteine (D) and homocysteine (E) concentrations
mothers smoked. Data from individual fetuses (A–D: 11–16 fetuses per gro
represents the mean of the group. Significant differences between groups
element or compound, groups that do not share a letter are significantly (P
mothers; Sm, represents smoke-exposed fetuses from mothers who smokeEffects of smoke exposure
In females, both vitamin B12 and cobalt concentrations
correlated significantly and inversely with fetal cotinine
(r = −0.593, P = 0.002 and r = −0.510, P = 0.009, respec-
tively) and levels of both were significantly reduced by
maternal cigarette smoking to resemble the levels seen
in males (Figure 2A, B and Additional file 2: Table S2).
In contrast, maternal smoking was associated with a
significant increase in the vitamin B12/cobalt ratio
across the second trimester in males (Additional file 3:
Figure S1). This reflects a decrease in the proportion of
cobalt that is not bound as cobalamin and demons-
trates that maternal smoking reduces non-cobalamin
cobalt uptake. We also measured fetal plasma homo-
cysteine and cysteine (to which homocysteine is con-
verted through the actions of cystathionine-β-synthase
and CTH). The sex differences in plasma homocysteine
and cysteine were abolished by exposure to maternal
smoking (Figure 2D, E).Expression of 1-carbon cycle genes and DNA
methyltransferases
Alterations in the expression of key genes in the 1-carbon
cycle (Additional file 4: Figure S2) might alter the avail-
ability of methyl groups and impact on DNA methylation.
We therefore measured the expression of mRNA tran-
scripts encoding enzymes in the 1-carbon cycle in fetal
liver (Figure 3A–I).uman fetal liver. (A) and (B) show the effects of sex and maternal
as lower in females and increased to male levels by smoke-exposure in
were significantly higher in male fetuses and this was lost when the
up; E–F: 13–17 fetuses per group) are shown, and the horizontal bar
are indicated by letters in the boxes above each graph. Within each
<0.05) different. NSm, represents control fetuses from non-smoking
d during pregnancy. Fetal sex is denoted by the appropriate symbol.
Figure 3 Expression of selected transcripts encoding members of the 1-Carbon cycle (A-I) and DNA methylation enzymes, (J) DNMT1,
(K) DNMT3A, (L) DNMT3B, in the human fetal liver and effects of sex and maternal smoking. Real-time PCR was used to measure specific
transcript levels as described in the text. Data from individual fetuses (11–16 fetuses per group) are shown, and the horizontal bar represents the
mean of the group. Significant differences between groups are indicated by letters in the boxes above each graph. Within each transcript, groups
that do not share a letter are significantly (P <0.05) different. NSm, represents control fetuses from non-smoking mothers; Sm, represents smoke-
exposed fetuses from mothers who smoked during pregnancy. Fetal sex is denoted by the appropriate symbol.
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Sex differences in transcript levels were apparent, with lo-
wer expression of MTR, MTRR, methylene-THF-reductase
(MTHFR), glycine N-methyltransferase (GNMT), and CTH
in non-exposed males compared to females. In addition,
expression of the DNA methyltransferase DNMT1 was
higher and the expression of DNMT3B was lower in males
compared to females (Figure 3J–L).
Effects of smoke exposure
Exposure to maternal smoking was associated with sex-
specific changes in mRNA transcript levels: in males,
smoke exposure resulted in an increase in the expression
of CTH and MTRR to female levels but also resulted in a
decrease in the expression of MTR. In females, smokeexposure resulted in an increase in the expression of
MTR and a decrease in the expression of GNMT to male
levels. The expression of DNMT1 in males was reduced
to female levels by exposure to maternal smoking but
there were no effects of smoking on the expression of
DNMT3A or DNMT3B (Figure 3J–L).Expression of IGF2 and NR3C1 (GR)
Effects of fetal sex
The expression of the IGF2 transcript was higher in
males compared to females (Figure 4A) whereas ex-
pression of the glucocorticoid receptor (GR/NR3C1)
was lower in males (P = 0.022, Figure 4B) compared to
females.
Figure 4 Effects of fetal sex and maternal smoking on expression of transcripts encoding IGF2 (A) and GR (B), and on DNA methylation
(C and D) in the human fetal liver. Real-time PCR was used to measure specific transcript levels and pyrosequencing was used to analyze DNA
methylation as described in the text. Data from individual fetuses (11–16 fetuses per group) are shown, and the horizontal bar represents the
mean of the group. In A and B, significant differences between groups are indicated by letters in the boxes above each graph. Within each
transcript, groups that do not share a letter are significantly (P <0.05) different. NSm, represents control fetuses from non-smoking mothers; Sm,
represents smoke-exposed fetuses from mothers who smoked during pregnancy. Fetal sex is denoted by the appropriate symbol.
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The expression of IGF2 transcript was decreased by
smoke exposure in males but there was no effect in fe-
males (Figure 4A). There was no effect of smoking on
the expression of GR (Figure 4B).
DNA methylation of IGF2 and NR3C1 (GR)
Pyrosequencing was used to quantify DNA methylation
at the DMRs known to be important in the control of
IGF2 expression: DMR0, DMR2, and the H19 ICR, which
lies upstream of the H19 gene. There was a significant
(P <0.05) increase in DNA methylation at IGF2 DMR0
with gestational age (Additional file 5: Figure S3A).
Levels of DNA methylation at exons 1C and 1F of the
GR/NR3C1 promoter were very low as previously pub-
lished [31], consistent with the status of the GR promoter
as a dense CpG island. Methylation at exon 1C increased
with gestational age (Additional file 5: Figure S3B).
Effects of fetal sex
Sex differences in DNA methylation were apparent at
the H19 ICR and IGF2 DMR2, where methylation was
lower in males than females. Conversely, at the GR pro-
moter there was higher DNA methylation within exon1F (with a similar trend for exon IC, P = 0.056) in males,
consistent with the lower transcript levels of this gene
(Figure 4C).
Effects of smoke exposure
In males, smoke exposure significantly increased DNA
methylation at one CpG within the H19 ICR (Figure 4D),
whereas in females, smoke exposure was associated with
decreased methylation at several CpGs within IGF2 DMR2.
Additionally, at the GR promoter, there were small changes
in DNA methylation associated with maternal smoking at
specific CpGs within exon 1F in males and at one CpG in
exon 1C in females (Figure 4D).
Discussion
Vitamin B12 is an essential component of the 1-carbon
cycle and data from both human and animal studies
strongly support the concept that maternal and/or fetal
vitamin B12 availability has important influences on health
outcomes, including fetal growth, neurodevelopment, and
longer term cardiometabolic disease risk [34-36]. Herein,
we show, for the first time, that maternal smoking, which
is known to reduce the concentrations of vitamin B12 in
pregnant women and their infants [17,18], is associated
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ing alterations in levels of enzyme transcripts and co-
factors. Importantly, we also show that these effects are
present during early development and in a key target tis-
sue, the fetal liver.
The precise role of in utero methyl donor availability
and/or effects on the 1-carbon pathway in the program-
ming of later disease risk remains unknown; however,
one important mechanism may be through changes in
DNA methylation [11]. In animal models, dietary avail-
ability of methyl donors during pregnancy has a profound
influence on both phenotype and DNA methylation in
offspring [12,37]. In humans, maternal vitamin B12 con-
centrations correlate inversely with global DNA me-
thylation in umbilical cord blood [15], and an inverse
correlation between cord plasma homocysteine concen-
trations and genome-wide DNA methylation at repe-
titive sequences has been reported [38]. Additionally,
genome-wide and candidate gene studies have identi-
fied alterations in DNA methylation in association with
maternal smoking in accessible tissues at birth, inclu-
ding cord blood, buccal cells, and placenta [8-10]. Our
findings that maternal smoking is associated with effects
on DNA methylation strengthen and extend previous
studies by showing that such changes are detectable in the
fetal liver, a major target organ for developmental pro-
gramming effects [39,40], and that they are present during
early development.
The imprinted gene IGF2 has a major role in mediat-
ing fetal growth [41] and altered DNA methylation at
the IGF2 DMRs is known to be associated with human
syndromic growth disorders, including Silver Russell and
Beckwith Wiedemann syndromes [42]. Recent data sug-
gest that more subtle alterations in DNA methylation at
IGF2 are associated with patterns of fetal growth within
the normal range [43-46] and some studies report that
infants born small for gestational age have reduced DNA
methylation at IGF2 in cord blood [43]. Thus, reduced
IGF2 methylation in fetal liver during early-mid gestation
could be one mechanism for the reduction in birthweight
seen with prenatal smoke exposure. DNA methylation at
IGF2 appears to be particularly sensitive to the prenatal
environment [9,47,48] and our data support the concept
that methylation at IGF2 may be a useful marker of in
utero exposures [9]. DNA methylation at GR may also be
influenced by diverse environmental cues in early life and
animal and human studies suggest that downstream ef-
fects on the expression of GR may play a role in mediating
the associations between the early life environment and
subsequent cardiometabolic and neuropsychiatric disor-
ders [31,39,49,50]. The methylation changes we report at
both IGF2 and GR in association with smoke exposure are
relatively small; however, they resemble those described
in previous studies, including studies of prenatal smokeexposure [9,47,51]. Additionally, the observed alterations
in DNA methylation were region- and CpG site-specific,
consistent with reports in both animal models and human
studies [31,52]. In agreement with previously published
studies in humans, DNA methylation levels did not neces-
sarily predict changes in transcript levels, notably at IGF2,
suggesting that there are alternative and/or additional
mechanisms driving changes in transcript expression [53].
Rather, such changes in DNA methylation may result in
genes being ‘poised’ for activation in response to future
events [53,54].
Sex differences were evident in DNA methylation, which
was higher at IGF2 and lower at GR in females compared
with males and the most marked changes in DNA methy-
lation in association with maternal smoking occurred at
these loci. Sexually dimorphic changes in DNA methyla-
tion have been reported as a consequence of early life nu-
tritional challenges and exposure to maternal smoking
[9,51,55,56]. The proposed mechanisms to explain these
observations include differences in the timing and speed
of development, the influence of sex steroids, especially
androgens, and/or sex chromosome complement [22,57].
Our results suggest that sex differences in the concen-
trations of vitamin B12 and homocysteine and in the
expression of genes important in 1-carbon metabolism
and DNA methylation could also be important in deter-
mining the sex-specific effects of exposure to an adverse
environment in early life. Consistent with our previous
studies [21,22], the smoke-induced changes in cobalt, vita-
min B12, and homocysteine, and in the expression of
enzymes involved in both the 1-carbon cycle and DNA
methylation, resulted in profiles which resembled those
seen in the opposite sex (summarized in Figure 5). These
clearly suggest that smoke exposure results in masculini-
zation of the female liver and feminization of the male
liver (Figure 5).
Temporal changes in gene expression and DNA me-
thylation indicate that there may be specific windows of
susceptibility during development and, importantly, that
this is likely to differ between the sexes. Allelic methyla-
tion patterns at the IGF2 DMRs arise early in embryo-
genesis and change progressively during development
[58] and here we show that this is also the case for GR
between 12 and 20 weeks of gestation. Thus, since a
worryingly high proportion of women continue to smoke
throughout pregnancy, the observed effects on DNA
methylation may change or become amplified with on-
going exposure. Additionally, the temporal changes in
DNA methylation profiles across gestation could be one
explanation for the differences between studies with re-
spect to the association of DNA methylation at IGF2 and
fetal growth [9,59]. Whilst the data shown here represent
a single, albeit unique, 10-week snap-shot of the effects
of maternal smoking, they are consistent with previous
Figure 5 Summary of effects of fetal sex and maternal smoking on the human fetal second trimester liver 1-carbon metabolism
pathway. Redrawn and modified from [10]. In 7 out of 8 genes or compounds showing sex differences, maternal smoking reduced the
magnitude of the difference. Together with sex differences and sex-specific effects of maternal smoking on DNA methylation this demonstrates
the sensitivity of the fetal liver to maternal smoking.
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with altered DNA methylation in blood, buccal cells,
and placenta in exposed offspring at birth [8]. Import-
antly, these changes may be persistent and/or evolve
postnatally since DNA methylation patterns in periph-
eral blood and buccal cells in young children and in
peripheral blood in adolescence and young adulthood
also associate with in utero exposure to maternal smoking[7,10,60,61]. Furthermore, some studies report that me-
thylation differences only become apparent some consid-
erable time after in utero environmental exposures [51].
Conclusions
Our novel data greatly extend previous studies linking in
utero exposures with altered DNA methylation by sho-
wing, for the first time, that such changes are present
Drake et al. BMC Medicine  (2015) 13:18 Page 10 of 12comparatively early in fetal life and, importantly, that
these occur in a key metabolic target tissue, the liver.
These changes are likely to have a direct effect on fetal
development and, if persistent, may have long-term effects
on health. Additionally these data propose an important
new mechanism by which these changes might be in-
duced, through alterations in methyl donor availability
and changes in the 1-carbon cycle.
Additional files
Additional file 1: Primers used for qPCR.
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Additional file 3: Maternal smoking is associated with a significant
increase in the ration between hepatic Co and vitamin B12 in males
fetuses only across the second trimester. Males are shown by squares,
females by circles, controls are open, smoke-exposed are shaded. “NSm”
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